
1. International network of cancer genome projects
Citations:1421
Authors: International Cancer Genome Consortium
Publication: Nature 464 (7291), 993

4. Hotspot Mutations in< i> H3F3A</i> and< i> IDH1</i> Define Distinct Epigenetic and Biological Subgroups of Glioblastoma
Citations:1052
Authors: D Sturm, H Witt, V Hovestadt, DA Khuong-Quang, DTW Jones, ...
Publication: Cancer Cell 22 (4), 425-437

5. Medulloblastoma comprises four distinct molecular variants
Citations:971
Authors: PA Northcott, A Korshunov, H Witt, T Hielscher, CG Eberhart, S Mack, ...
Publication: Journal of clinical oncology 29 (11), 1408

8. Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations
Citations:642
Authors: MC Thompson, C Fuller, TL Hogg, J Dalton, D Finkelstein, CC Lau, ...
Publication: Journal of clinical oncology 24 (12), 1924-1931

9. The genetic landscape of the childhood cancer medulloblastoma
Citations:631
Authors: DW Parsons, M Li, X Zhang, S Jones, RJ Leary, JCH Lin, SM Boca, ...
Publication: science 331 (6016), 435-439

10. The genetic landscape of the childhood cancer medulloblastoma
Citations:631
Authors: DW Parsons, M Li, X Zhang, S Jones, RJ Leary, JCH Lin, SM Boca, ...
Publication: science 331 (6016), 435-439

11. Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
Citations:629
Authors: M Kool, A Korshunov, M Remke, DTW Jones, M Schlanstein, PA Northcott, ...
Publication: Acta Neuropathologica, 1-12

12. Dissecting the genomic complexity underlying medulloblastoma
Citations:626
Authors: DTW Jones, N Jäger, M Kool, T Zichner, B Hutter, M Sultan, YJ Cho, ...
Publication: Nature

13. Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations
Citations:574
Authors: T Rausch, DTW Jones, M Zapatka, AM Stütz, T Zichner, J Weischenfeldt, ...
Publication: Cell 148 (1-2), 59-71

14. Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations
Citations:569
Authors: TJ Pugh, SD Weeraratne, TC Archer, DAP Krummel, D Auclair, ...
Publication: Nature 488 (7409), 106

15. Subgroup-specific structural variation across 1,000 medulloblastoma genomes
Citations:554
Authors: PA Northcott, DJH Shih, J Peacock, L Garzia, AS Morrissy, T Zichner, ...
Publication: Nature 488 (7409), 49

16. Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma
Citations:448
Authors: DTW Jones, B Hutter, N Jäger, A Korshunov, M Kool, HJ Warnatz, ...
Publication: Nature genetics 45 (8), 927

17. Medulloblastomics: the end of the beginning
Citations:445
Authors: PA Northcott, DTW Jones, M Kool, GW Robinson, RJ Gilbertson, YJ Cho, ...
Publication: Nature Reviews Cancer 12 (12), 818

18. Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups
Citations:400
Authors: KW Pajtler, H Witt, M Sill, DTW Jones, V Hovestadt, F Kratochwil, K Wani, ...
Publication: Cancer Cell 27 (5), 728-743

19. Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition
Citations:400
Authors: M Kool, DTW Jones, N Jäger, PA Northcott, TJ Pugh, V Hovestadt, ...
Publication: Cancer cell 25 (3), 393-405

20. Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma
Citations:394
Authors: PA Northcott, Y Nakahara, X Wu, L Feuk, DW Ellison, S Croul, S Mack, ...
Publication: Nature genetics 41 (4), 465

21. Epigenomic alterations define lethal CIMP-positive ependymomas of infancy
Citations:373
Authors: SC Mack, H Witt, RM Piro, L Gu, S Zuyderduyn, AM Stütz, X Wang, ...
Publication: Nature 506 (7489), 445

22. Clonal selection drives genetic divergence of metastatic medulloblastoma
Citations:355
Authors: X Wu, PA Northcott, A Dubuc, AJ Dupuy, DJH Shih, H Witt, S Croul, ...
Publication: Nature

23. Clonal selection drives genetic divergence of metastatic medulloblastoma
Citations:355
Authors: X Wu, PA Northcott, A Dubuc, AJ Dupuy, DJH Shih, H Witt, S Croul, ...
Publication: Nature 482 (7386), 529

24. Clonal selection drives genetic divergence of metastatic medulloblastoma
Citations:355
Authors: X Wu, PA Northcott, A Dubuc, AJ Dupuy, DJH Shih, H Witt, S Croul, ...
Publication: Nature 482 (7386), 529

26. Delineation of Two Clinically and Molecularly Distinct Subgroups of Posterior Fossa Ependymoma
Citations:327
Authors: H Witt, SC Mack, M Ryzhova, S Bender, M Sill, R Isserlin, A Benner, ...
Publication: Cancer Cell 20 (2), 143-157

27. Immune checkpoint inhibition for hypermutant glioblastoma multiforme resulting from germline biallelic mismatch repair deficiency
Citations:326
Authors: E Bouffet, V Larouche, BB Campbell, D Merico, R De Borja, M Aronson, ...
Publication: Journal of clinical oncology 34 (19), 2206-2211

28. YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation
Citations:310
Authors: A Fernandez-L, PA Northcott, J Dalton, C Fraga, D Ellison, S Angers, ...
Publication: Genes & development 23 (23), 2729-2741

29. Cross-species genomics matches driver mutations and cell compartments to model ependymoma
Citations:287
Authors: RA Johnson, KD Wright, H Poppleton, KM Mohankumar, D Finkelstein, ...
Publication: Nature 466 (7306), 632

30. The miR-17/92 polycistron is up-regulated in Sonic Hedgehog–driven medulloblastomas and induced by N-myc in Sonic Hedgehog–treated cerebellar neural precursors
Citations:286
Authors: PA Northcott, A Fernandez-L, JP Hagan, DW Ellison, W Grajkowska, ...
Publication: Cancer research 69 (8), 3249-3255

31. MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma
Citations:280
Authors: L Garzia, I Andolfo, E Cusanelli, N Marino, G Petrosino, D De Martino, ...
Publication: PLoS one 4 (3), e4998

32. New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs
Citations:271
Authors: D Sturm, BA Orr, UH Toprak, V Hovestadt, DTW Jones, D Capper, M Sill, ...
Publication: Cell 164 (5), 1060-1072

33. Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma
Citations:268
Authors: PA Northcott, C Lee, T Zichner, AM Stütz, S Erkek, D Kawauchi, DJH Shih, ...
Publication: Nature 511 (7510), 428

34. The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation
Citations:257
Authors: G Leprivier, M Remke, B Rotblat, A Dubuc, ARF Mateo, M Kool, ...
Publication: Cell 153 (5), 1064-1079

35. DNA methylation-based classification of central nervous system tumours
Citations:253
Authors: D Capper, DTW Jones, M Sill, V Hovestadt, D Schrimpf, D Sturm, ...
Publication: Nature 555 (7697), 469

36. DNA methylation-based classification of central nervous system tumours
Citations:253
Authors: D Capper, DTW Jones, M Sill, V Hovestadt, D Schrimpf, D Sturm, ...
Publication: Nature 555 (7697), 469

37. Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples
Citations:245
Authors: PA Northcott, DJH Shih, M Remke, YJ Cho, M Kool, C Hawkins, ...
Publication: Acta neuropathologica 123 (4), 615-626

38. Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples
Citations:245
Authors: PA Northcott, DJH Shih, M Remke, YJ Cho, M Kool, C Hawkins, ...
Publication: Acta neuropathologica 123 (4), 615-626

39. An animal model of MYC-driven medulloblastoma
Citations:234
Authors: Y Pei, CE Moore, J Wang, AK Tewari, A Eroshkin, YJ Cho, H Witt, ...
Publication: Cancer cell 21 (2), 155-167

40. An Animal Model of MYC-Driven Medulloblastoma
Citations:234
Authors: Y Pei, CE Moore, J Wang, AK Tewari, A Eroshkin, YJ Cho, H Witt, ...
Publication: Cancer Cell 21 (2), 155-167

41. Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing
Citations:232
Authors: V Hovestadt, DTW Jones, S Picelli, W Wang, M Kool, PA Northcott, ...
Publication: Nature 510 (7506), 537

42. Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma
Citations:229
Authors: N Zhukova, V Ramaswamy, M Remke, E Pfaff, DJH Shih, DC Martin, ...
Publication: Journal of Clinical Oncology 31 (23), 2927

44. Intertumoral Heterogeneity within Medulloblastoma Subgroups
Citations:210
Authors: FMG Cavalli, M Remke, L Rampasek, J Peacock, DJH Shih, B Luu, ...
Publication: Cancer Cell 31 (6), 737-754. e6

45. Combined hereditary and somatic mutations of replication error repair genes result in rapid onset of ultra-hypermutated cancers
Citations:196
Authors: A Shlien, BB Campbell, R de Borja, LB Alexandrov, D Merico, D Wedge, ...
Publication: Nature genetics 47 (3), 257

46. Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis
Citations:188
Authors: V Ramaswamy, M Remke, E Bouffet, CC Faria, S Perreault, YJ Cho, ...
Publication: The lancet oncology 14 (12), 1200-1207

47. The whole-genome landscape of medulloblastoma subtypes
Citations:186
Authors: PA Northcott, I Buchhalter, AS Morrissy, V Hovestadt, J Weischenfeldt, ...
Publication: Nature 547 (7663), 311

48. Cytogenetic prognostication within medulloblastoma subgroups
Citations:186
Authors: DJH Shih, PA Northcott, M Remke, A Korshunov, V Ramaswamy, M Kool, ...
Publication: Journal of Clinical Oncology 32 (9), 886

49. Frequent amplification of a chr19q13. 41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors
Citations:184
Authors: M Li, KF Lee, Y Lu, I Clarke, D Shih, C Eberhart, VP Collins, T Van Meter, ...
Publication: Cancer cell 16 (6), 533-546

50. Adult medulloblastoma comprises three major molecular variants
Citations:182
Authors: M Remke, T Hielscher, PA Northcott, H Witt, M Ryzhova, A Wittmann, ...
Publication: Journal of Clinical Oncology 29 (19), 2717-2723

52. Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes
Citations:175
Authors: PD Johann, S Erkek, M Zapatka, K Kerl, I Buchhalter, V Hovestadt, ...
Publication: Cancer cell 29 (3), 379-393

53. Risk stratification of childhood medulloblastoma in the molecular era: the current consensus
Citations:169
Authors: V Ramaswamy, M Remke, E Bouffet, S Bailey, SC Clifford, F Doz, M Kool, ...
Publication: Acta neuropathologica 131 (6), 821-831

54. Divergent clonal selection dominates medulloblastoma at recurrence
Citations:169
Authors: AS Morrissy, L Garzia, DJH Shih, S Zuyderduyn, X Huang, P Skowron, ...
Publication: Nature 529 (7586), 351

55. Divergent clonal selection dominates medulloblastoma at recurrence
Citations:169
Authors: AS Morrissy, L Garzia, DJH Shih, S Zuyderduyn, X Huang, P Skowron, ...
Publication: Nature 529 (7586), 351

57. Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays
Citations:168
Authors: V Hovestadt, M Remke, M Kool, T Pietsch, PA Northcott, R Fischer, ...
Publication: Acta neuropathologica 125 (6), 913-916

58. Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct
Citations:167
Authors: PA Northcott, T Hielscher, A Dubuc, S Mack, D Shih, M Remke, ...
Publication: Acta neuropathologica 122 (2), 231-240

61. HDAC5 and HDAC9 in medulloblastoma: novel markers for risk stratification and role in tumor cell growth
Citations:156
Authors: T Milde, I Oehme, A Korshunov, A Kopp-Schneider, M Remke, P Northcott, ...
Publication: Clinical Cancer Research 16 (12), 3240-3252

62. Comprehensive Analysis of Hypermutation in Human Cancer
Citations:153
Authors: BB Campbell, N Light, D Fabrizio, M Zatzman, F Fuligni, R de Borja, ...
Publication: Cell 171 (5), 1042-1056. e10

63. Distinct Neural Stem Cell Populations Give Rise to Disparate Brain Tumors in Response to N-MYC
Citations:153
Authors: FJ Swartling, V Savov, AI Persson, J Chen, CS Hackett, PA Northcott, ...
Publication: Cancer Cell 21 (5), 601-613

64. Pleiotropic role for MYCN in medulloblastoma
Citations:150
Authors: FJ Swartling, MR Grimmer, CS Hackett, PA Northcott, QW Fan, ...
Publication: Genes & development 24 (10), 1059-1072

65. Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study
Citations:147
Authors: P Castelo-Branco, S Choufani, S Mack, D Gallagher, C Zhang, T Lipman, ...
Publication: The lancet oncology 14 (6), 534-542

66. Quiescent Sox2+ Cells Drive Hierarchical Growth and Relapse in Sonic Hedgehog Subgroup Medulloblastoma
Citations:145
Authors: RJ Vanner, M Remke, M Gallo, HJ Selvadurai, F Coutinho, L Lee, ...
Publication: Cancer cell 26 (1), 33-47

69. FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma
Citations:140
Authors: M Remke, T Hielscher, A Korshunov, PA Northcott, S Bender, M Kool, ...
Publication: J Clin Oncol 29 (29), 3852-3861

70. FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma
Citations:140
Authors: M Remke, T Hielscher, A Korshunov, PA Northcott, S Bender, M Kool, ...
Publication: J Clin Oncol 29 (29), 3852-3861

71. MRI surrogates for molecular subgroups of medulloblastoma
Citations:137
Authors: S Perreault, V Ramaswamy, AS Achrol, K Chao, TT Liu, D Shih, M Remke, ...
Publication: American Journal of Neuroradiology 35 (7), 1263-1269

72. WNT ACTIVATION BY LITHIUM ABROGATES MUTANT TP53 RADIATION RESISTANCE IN MEDULLOBLASTOMA
Citations:135
Authors: N Zhukova, D Martin, T Lipman, P Castelo-Branco, C Zhang, M Fraser, ...
Publication: NEURO-ONCOLOGY 14, 100-100

73. BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma
Citations:126
Authors: M Mistry, N Zhukova, D Merico, P Rakopoulos, R Krishnatry, M Shago, ...
Publication: Journal of clinical oncology 33 (9), 1015

74. Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological …
Citations:126
Authors: A Korshunov, D Sturm, M Ryzhova, V Hovestadt, M Gessi, DTW Jones, ...
Publication: Acta neuropathologica 128 (2), 279-289

77. Sonic hedgehog regulates Bmi1 in human medulloblastoma brain tumor-initiating cells
Citations:123
Authors: X Wang, C Venugopal, B Manoranjan, N McFarlane, E O'farrell, S Nolte, ...
Publication: Oncogene 31 (2), 187

79. Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMR
Citations:115
Authors: CL Kleinman, N Gerges, S Papillon-Cavanagh, P Sin-Chan, ...
Publication: Nature genetics 46 (1), 39

81. Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma
Citations:114
Authors: AM Dubuc, M Remke, A Korshunov, PA Northcott, SH Zhan, ...
Publication: Acta Neuropathologica, 1-12

82. Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity
Citations:110
Authors: KM Turner, V Deshpande, D Beyter, T Koga, J Rusert, C Lee, B Li, ...
Publication: Nature 543 (7643), 122

83. The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants
Citations:109
Authors: KW Pajtler, SC Mack, V Ramaswamy, CA Smith, H Witt, A Smith, ...
Publication: Acta neuropathologica 133 (1), 5-12

84. TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma
Citations:108
Authors: M Remke, V Ramaswamy, J Peacock, DJH Shih, C Koelsche, ...
Publication: Acta neuropathologica 126 (6), 917-929

85. Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis
Citations:107
Authors: EM Thompson, T Hielscher, E Bouffet, M Remke, B Luu, S Gururangan, ...
Publication: The Lancet Oncology 17 (4), 484-495

86. OTX2 is critical for the maintenance and progression of Shh-independent medulloblastomas
Citations:104
Authors: DC Adamson, Q Shi, M Wortham, PA Northcott, C Di, CG Duncan, J Li, ...
Publication: Cancer research 70 (1), 181-191

87. An epigenetic genome-wide screen identifies SPINT2 as a novel tumor suppressor gene in pediatric medulloblastoma
Citations:99
Authors: PN Kongkham, PA Northcott, YS Ra, Y Nakahara, TG Mainprize, SE Croul, ...
Publication: Cancer research 68 (23), 9945-9953

93. MicroRNA 218 acts as a tumor suppressor by targeting multiple cancer phenotype associated genes in medulloblastoma
Citations:96
Authors: S Venkataraman, DK Birks, I Balakrishnan, I Alimova, PS Harris, PR Patel, ...
Publication: Journal of Biological Chemistry

94. Fate mapping of human glioblastoma reveals an invariant stem cell hierarchy
Citations:91
Authors: X Lan, DJ Jörg, FMG Cavalli, LM Richards, LV Nguyen, RJ Vanner, ...
Publication: Nature 549 (7671), 227

95. TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma
Citations:91
Authors: E Pfaff, M Remke, D Sturm, A Benner, H Witt, T Milde, AO von Bueren, ...
Publication: J Clin Oncol 28 (35), 5188-5196

99. CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity
Citations:89
Authors: T Spence, P Sin-Chan, D Picard, M Barszczyk, K Hoss, M Lu, SK Kim, ...
Publication: Acta neuropathologica 128 (2), 291-303

100. Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group
Citations:87
Authors: NG Gottardo, JR Hansford, JP McGlade, F Alvaro, DM Ashley, S Bailey, ...
Publication: Acta neuropathologica 127 (2), 189-201

101. DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies.
Citations:85
Authors: EC Schwalbe, D Williamson, JC Lindsey, D Hamilton, SL Ryan, ...
Publication: Acta neuropathologica

102. Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort
Citations:83
Authors: T Pietsch, R Schmidt, M Remke, A Korshunov, V Hovestadt, DTW Jones, ...
Publication: Acta neuropathologica 128 (1), 137-149

104. Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysis
Citations:81
Authors: J Torchia, D Picard, L Lafay-Cousin, CE Hawkins, SK Kim, L Letourneau, ...
Publication: The Lancet Oncology 16 (5), 569-582

106. Rapid diagnosis of medulloblastoma molecular subgroups
Citations:79
Authors: EC Schwalbe, JC Lindsey, D Straughton, TL Hogg, M Cole, H Megahed, ...
Publication: Clinical Cancer Research 17 (7), 1883-1894

110. Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: a retrospective multicohort analysis
Citations:75
Authors: V Ramaswamy, T Hielscher, SC Mack, A Lassaletta, T Lin, KW Pajtler, ...
Publication: Journal of Clinical Oncology 34 (21), 2468

111. HDAC and PI3K Antagonists Cooperate to Inhibit Growth of MYC-Driven Medulloblastoma
Citations:75
Authors: Y Pei, KW Liu, J Wang, A Garancher, R Tao, LA Esparza, DL Maier, ...
Publication: Cancer Cell 29 (3), 311-323

112. Genetic and epigenetic inactivation of Kruppel-like factor 4 in medulloblastoma
Citations:72
Authors: Y Nakahara, PA Northcott, M Li, PN Kongkham, C Smith, H Yan, S Croul, ...
Publication: Neoplasia 12 (1), 20-27

113. Medulloblastoma subgroup-specific outcomes in irradiated children: who are the true high-risk patients?
Citations:71
Authors: V Ramaswamy, M Remke, J Adamski, U Bartels, U Tabori, X Wang, ...
Publication: Neuro-oncology 18 (2), 291-297

114. Medulloblastoma subgroup-specific outcomes in irradiated children: who are the true high-risk patients?
Citations:71
Authors: V Ramaswamy, M Remke, J Adamski, U Bartels, U Tabori, X Wang, ...
Publication: Neuro-oncology 18 (2), 291-297

115. The G protein α subunit Gαs is a tumor suppressor in Sonic hedgehog−driven medulloblastoma
Citations:71
Authors: X He, L Zhang, Y Chen, M Remke, D Shih, F Lu, H Wang, Y Deng, Y Yu, ...
Publication: Nature medicine 20 (9), 1035

116. The G protein α subunit Gαs is a tumor suppressor in Sonic hedgehog−driven medulloblastoma
Citations:71
Authors: X He, L Zhang, Y Chen, M Remke, D Shih, F Lu, H Wang, Y Deng, Y Yu, ...
Publication: Nature medicine 20 (9), 1035

117. Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma
Citations:71
Authors: S Venkataraman, I Alimova, I Balakrishnan, P Harris, DK Birks, ...
Publication: Oncotarget 5 (9), 2355

118. Coverage bias and sensitivity of variant calling for four whole-genome sequencing technologies
Citations:70
Authors: N Rieber, M Zapatka, B Lasitschka, D Jones, P Northcott, B Hutter, ...
Publication: PLoS One 8 (6), e66621

119. Personalizing the treatment of pediatric medulloblastoma: polo-like kinase 1 as a molecular target in high-risk children
Citations:67
Authors: J Triscott, C Lee, C Foster, B Manoranjan, MR Pambid, R Berns, ...
Publication: Cancer research 73 (22), 6734-6744

121. Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors
Citations:66
Authors: S Gholamin, SS Mitra, AH Feroze, J Liu, SA Kahn, M Zhang, R Esparza, ...
Publication: Science Translational Medicine 9 (381), eaaf2968

122. Role of LIM and SH3 protein 1 (LASP1) in the metastatic dissemination of medulloblastoma
Citations:66
Authors: C Traenka, M Remke, A Korshunov, S Bender, T Hielscher, PA Northcott, ...
Publication: Cancer research 70 (20), 8003-8014

124. Polo-like kinase 1 (PLK1) inhibition suppresses cell growth and enhances radiation sensitivity in medulloblastoma cells
Citations:65
Authors: PS Harris, S Venkataraman, I Alimova, DK Birks, AM Donson, J Knipstein, ...
Publication: BMC Cancer 12 (1), 80

125. Biological and clinical heterogeneity of MYCN-amplified medulloblastoma
Citations:63
Authors: A Korshunov, M Remke, M Kool, T Hielscher, PA Northcott, D Williamson, ...
Publication: Acta neuropathologica 123 (4), 515-527

126. Biological and clinical heterogeneity of MYCN-amplified medulloblastoma
Citations:63
Authors: A Korshunov, M Remke, M Kool, T Hielscher, PA Northcott, D Williamson, ...
Publication: Acta neuropathologica 123 (4), 515-527

127. Therapeutic and prognostic implications of BRAF V600E in pediatric low-grade gliomas
Citations:59
Authors: A Lassaletta, M Zapotocky, M Mistry, V Ramaswamy, M Honnorat, ...
Publication: Journal of Clinical Oncology 35 (25), 2934

129. Atypical teratoid or rhabdoid tumors: improved outcome with high-dose chemotherapy
Citations:58
Authors: T Finkelstein-Shechter, A Gassas, D Mabbott, A Huang, U Bartels, ...
Publication: Journal of Pediatric Hematology/Oncology 32 (5), e182-e186

130. Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors
Citations:57
Authors: J Torchia, B Golbourn, S Feng, KC Ho, P Sin-Chan, A Vasiljevic, ...
Publication: Cancer Cell 30 (6), 891-908

132. Targeting the enhancer of zeste homologue 2 in medulloblastoma
Citations:57
Authors: I Alimova, S Venkataraman, P Harris, VE Marquez, PA Northcott, A Dubuc, ...
Publication: International Journal of Cancer

133. Medulloblastoma subgroups remain stable across primary and metastatic compartments
Citations:54
Authors: X Wang, AM Dubuc, V Ramaswamy, S Mack, DMA Gendoo, M Remke, ...
Publication: Acta neuropathologica 129 (3), 449-457

137. Spatial heterogeneity in medulloblastoma
Citations:51
Authors: AS Morrissy, FMG Cavalli, M Remke, V Ramaswamy, DJH Shih, ...
Publication: Nature genetics 49 (5), 780

138. Genome-Wide Profiles of Extra-cranial Malignant Rhabdoid Tumors Reveal Heterogeneity and Dysregulated Developmental Pathways
Citations:51
Authors: HJE Chun, EL Lim, A Heravi-Moussavi, S Saberi, KL Mungall, M Bilenky, ...
Publication: Cancer Cell 29 (3), 394-406

140. MLL5 Orchestrates a Cancer Self-Renewal State by Repressing the Histone Variant H3. 3 and Globally Reorganizing Chromatin
Citations:51
Authors: M Gallo, FJ Coutinho, RJ Vanner, T Gayden, SC Mack, A Murison, ...
Publication: Cancer cell 28 (6), 715-729

141. CXCR4 activation defines a new subgroup of sonic Hedgehog–driven medulloblastoma
Citations:51
Authors: R Sengupta, A Dubuc, S Ward, L Yang, P Northcott, BM Woerner, K Kroll, ...
Publication: Cancer research 72 (1), 122-132

144. Hypermutation of the Inactive X Chromosome Is a Frequent Event in Cancer
Citations:50
Authors: N Jäger, M Schlesner, DTW Jones, S Raffel, JP Mallm, KM Junge, ...
Publication: Cell 155 (3), 567-581

145. Voltage-gated potassium channel EAG2 controls mitotic entry and tumor growth in medulloblastoma via regulating cell volume dynamics
Citations:50
Authors: X Huang, AM Dubuc, R Hashizume, J Berg, Y He, J Wang, C Chiang, ...
Publication: Genes & Development

146. FoxG1 Interacts with Bmi1 to Regulate Self‐Renewal and Tumorigenicity of Medulloblastoma Stem Cells
Citations:49
Authors: B Manoranjan, X Wang, RM Hallett, C Venugopal, SC Mack, N McFarlane, ...
Publication: Stem Cells 31 (7), 1266-1277

148. Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling
Citations:48
Authors: SC Mack, KW Pajtler, L Chavez, K Okonechnikov, KC Bertrand, X Wang, ...
Publication: Nature 553 (7686), 101

150. MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma
Citations:48
Authors: AHC Bai, T Milde, M Remke, CG Rolli, T Hielscher, YJ Cho, M Kool, ...
Publication: Acta neuropathologica 123 (4), 529-538

152. EPENDYMOMA
Citations:46
Authors: LM Hoffman, AM Donson, I Nakachi, AM Griesinger, DK Birks, V Amani, ...
Publication: Neuro-Oncology 16 (suppl 1), i17-i25

153. Epigenetic silencing of miRNA-9 is associated with HES1 oncogenic activity and poor prognosis of medulloblastoma
Citations:46
Authors: G Fiaschetti, L Abela, N Nonoguchi, AM Dubuc, M Remke, A Boro, ...
Publication: British journal of cancer 110 (3), 636

154. Nestin Expression Identifies Ependymoma Patients with Poor Outcome
Citations:46
Authors: T Milde, T Hielscher, H Witt, M Kool, SC Mack, HE Deubzer, I Oehme, ...
Publication: Brain Pathology

155. Silencing of thrombospondin-1 is critical for myc-induced metastatic phenotypes in medulloblastoma
Citations:46
Authors: L Zhou, D Picard, YS Ra, M Li, PA Northcott, Y Hu, D Stearns, C Hawkins, ...
Publication: Cancer research 70 (20), 8199-8210

159. The RNA-binding protein Musashi1 affects medulloblastoma growth via a network of cancer-related genes and is an indicator of poor prognosis
Citations:45
Authors: DT Vo, D Subramaniam, M Remke, TL Burton, PJ Uren, JA Gelfond, ...
Publication: The American journal of pathology 181 (5), 1762-1772

160. The RNA-binding protein Musashi1 affects medulloblastoma growth via a network of cancer-related genes and is an indicator of poor prognosis
Citations:45
Authors: DT Vo, D Subramaniam, M Remke, TL Burton, PJ Uren, JA Gelfond, ...
Publication: The American Journal of Pathology

161. Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome
Citations:44
Authors: P Panwalkar, J Clark, V Ramaswamy, D Hawes, F Yang, C Dunham, ...
Publication: Acta Neuropathologica 134 (5), 705-714

165. Molecular characterization of choroid plexus tumors reveals novel clinically relevant subgroups
Citations:41
Authors: DM Merino, A Shlien, A Villani, M Pienkowska, S Mack, V Ramaswamy, ...
Publication: Clinical Cancer Research 21 (1), 184-192

167. Clinical, Pathological, and Molecular Characterization of Infant Medulloblastomas Treated with Sequential High‐Dose Chemotherapy
Citations:40
Authors: L Lafay‐Cousin, A Smith, SN Chi, E Wells, J Madden, A Margol, ...
Publication: Pediatric blood & cancer 63 (9), 1527-1534

169. Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort
Citations:39
Authors: SM Waszak, PA Northcott, I Buchhalter, GW Robinson, C Sutter, ...
Publication: The Lancet Oncology 19 (6), 785-798

171. The Shh receptor Boc promotes progression of early medulloblastoma to advanced tumors
Citations:39
Authors: F Mille, L Tamayo-Orrego, M Lévesque, M Remke, A Korshunov, J Cardin, ...
Publication: Developmental cell 31 (1), 34-47

172. The Shh Receptor Boc Promotes Progression of Early Medulloblastoma to Advanced Tumors
Citations:39
Authors: F Mille, L Tamayo-Orrego, M Lévesque, M Remke, A Korshunov, J Cardin, ...
Publication: Developmental cell 31 (1), 34-47

173. The Shh Receptor Boc Promotes Progression of Early Medulloblastoma to Advanced Tumors
Citations:39
Authors: F Mille, L Tamayo-Orrego, M Lévesque, M Remke, A Korshunov, J Cardin, ...
Publication: Developmental cell 31 (1), 34-47

174. EAG2 potassium channel with evolutionarily conserved function as a brain tumor target
Citations:38
Authors: X Huang, Y He, AM Dubuc, R Hashizume, W Zhang, J Reimand, H Yang, ...
Publication: Nature neuroscience 18 (9), 1236

175. Shh Signaling Protects Atoh1 from Degradation Mediated by the E3 Ubiquitin Ligase Huwe1 in Neural Precursors
Citations:38
Authors: A Forget, L Bihannic, SM Cigna, C Lefevre, M Remke, M Barnat, S Dodier, ...
Publication: Developmental Cell 29 (6), 649-661

176. Targeting sonic hedgehog-associated medulloblastoma through inhibition of Aurora and Polo-like kinases
Citations:38
Authors: SL Markant, LA Esparza, J Sun, KL Barton, LM McCoig, GA Grant, ...
Publication: Cancer research 73 (20), 6310-6322

177. Tuberous sclerosis complex suppression in cerebellar development and medulloblastoma: separate regulation of mammalian target of rapamycin activity and p27Kip1 localization
Citations:38
Authors: B Bhatia, PA Northcott, D Hambardzumyan, B Govindarajan, DJ Brat, ...
Publication: Cancer research 69 (18), 7224-7234

178. Preclinical target validation using patient-derived cells
Citations:37
Authors: AM Edwards, CH Arrowsmith, C Bountra, ME Bunnage, M Feldmann, ...
Publication: Nature Reviews Drug Discovery 14 (3), 149

179. Monoallelic expression determines oncogenic progression and outcome in benign and malignant brain tumors
Citations:36
Authors: EJ Walker, C Zhang, P Castelo-Branco, C Hawkins, W Wilson, N Zhukova, ...
Publication: Cancer research 72 (3), 636-644

182. Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk Neuroblastoma
Citations:35
Authors: KR Bosse, P Raman, Z Zhu, M Lane, D Martinez, S Heitzeneder, KS Rathi, ...
Publication: Cancer Cell 32 (3), 295-309. e12

183. The WIP1 oncogene promotes progression and invasion of aggressive medulloblastoma variants
Citations:35
Authors: MC Buss, M Remke, J Lee, K Gandhi, MJ Schniederjan, M Kool, ...
Publication: Oncogene 34 (9), 1126

184. Foretinib is effective therapy for metastatic sonic hedgehog medulloblastoma
Citations:35
Authors: CC Faria, BJ Golbourn, AM Dubuc, M Remke, RJ Diaz, S Agnihotri, ...
Publication: Cancer research 75 (1), 134-146

186. ATM regulates 3-methylpurine-DNA glycosylase and promotes therapeutic resistance to alkylating agents
Citations:34
Authors: S Agnihotri, K Burrell, P Buczkowicz, M Remke, B Golbourn, ...
Publication: Cancer discovery 4 (10), 1198-1213

190. Integrated genomic analysis identifies the mitotic checkpoint kinase WEE1 as a novel therapeutic target in medulloblastoma
Citations:32
Authors: PS Harris, S Venkataraman, I Alimova, DK Birks, I Balakrishnan, ...
Publication: Molecular cancer 13 (1), 72

191. Deconstruction of medulloblastoma cellular heterogeneity reveals differences between the most highly invasive and self-renewing phenotypes
Citations:32
Authors: LC Morrison, R McClelland, C Aiken, M Bridges, L Liang, X Wang, ...
Publication: Neoplasia (New York, NY) 15 (4), 384

192. Deconstruction of Medulloblastoma Cellular Heterogeneity Reveals Differences between the Most Highly Invasive and Self-Renewing Phenotypes
Citations:32
Authors: LC Morrison, R McClelland, C Aiken, M Bridges, L Liang, X Wang, ...
Publication: Neoplasia (New York, NY) 15 (4), 384

196. PCDH10 is a candidate tumour suppressor gene in medulloblastoma
Citations:30
Authors: KC Bertrand, SC Mack, PA Northcott, L Garzia, A Dubuc, SM Pfister, ...
Publication: Child's Nervous System 27 (8), 1243-1249

201. Alternative lengthening of telomeres is enriched in, and impacts survival of TP53 mutant pediatric malignant brain tumors
Citations:28
Authors: J Mangerel, A Price, P Castelo-Branco, J Brzezinski, P Buczkowicz, ...
Publication: Acta neuropathologica 128 (6), 853-862

202. Duration of the pre‐diagnostic interval in medulloblastoma is subgroup dependent
Citations:28
Authors: V Ramaswamy, M Remke, D Shih, X Wang, PA Northcott, CC Faria, ...
Publication: Pediatric blood & cancer 61 (7), 1190-1194

203. ABC transporter activity linked to radiation resistance and molecular subtype in pediatric medulloblastoma
Citations:28
Authors: WJ Ingram, LM Crowther, EB Little, R Freeman, I Harliwong, D Veleva, ...
Publication: Experimental hematology & oncology 2 (1), 26

204. PINK1 is a negative regulator of growth and the Warburg effect in glioblastoma
Citations:27
Authors: S Agnihotri, B Golbourn, X Huang, M Remke, S Younger, RA Cairns, ...
Publication: Cancer research 76 (16), 4708-4719

205. Spinal myxopapillary ependymomas demonstrate a warburg phenotype
Citations:27
Authors: SC Mack, S Agnihotri, KC Bertrand, X Wang, DJ Shih, H Witt, N Hill, ...
Publication: Clinical Cancer Research 21 (16), 3750-3758

208. MEDULLOBLASTOMA
Citations:27
Authors: KKW Li, JCS Pang, HK Ng, M Massimino, L Gandola, V Biassoni, ...
Publication: Neuro-Oncology 14 (suppl 1), i82-i105

209. Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas
Citations:26
Authors: KW Pajtler, J Wen, M Sill, T Lin, W Orisme, B Tang, JM Hübner, ...
Publication: Acta neuropathologica 136 (2), 211-226

210. Medulloblastoma-associated DDX3 variant selectively alters the translational response to stress
Citations:26
Authors: S Oh, RA Flynn, SN Floor, J Purzner, L Martin, BT Do, S Schubert, D Vaka, ...
Publication: Oncotarget 7 (19), 28169

211. Clinical implications of medulloblastoma subgroups: incidence of CSF diversion surgery
Citations:26
Authors: C Schneider, V Ramaswamy, AV Kulkarni, JT Rutka, M Remke, U Tabori, ...
Publication: Journal of Neurosurgery: Pediatrics 15 (3), 236-242

213. WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastoma
Citations:25
Authors: N Zhukova, V Ramaswamy, M Remke, DC Martin, P Castelo-Branco, ...
Publication: Acta neuropathologica communications 2 (1), 174

215. Telomerase inhibition abolishes the tumorigenicity of pediatric ependymoma tumor-initiating cells
Citations:24
Authors: M Barszczyk, P Buczkowicz, P Castelo-Branco, SC Mack, V Ramaswamy, ...
Publication: Acta neuropathologica 128 (6), 863-877

216. Overcoming resistance to sonic hedgehog inhibition by targeting p90 ribosomal S6 kinase in pediatric medulloblastoma
Citations:24
Authors: MR Pambid, R Berns, HH Adomat, K Hu, J Triscott, N Maurer, N Zisman, ...
Publication: Pediatric blood & cancer 61 (1), 107-115

217. Subgroup-specific alternative splicing in medulloblastoma
Citations:23
Authors: AM Dubuc, AS Morrissy, NK Kloosterhof, PA Northcott, EPY Yu, D Shih, ...
Publication: Acta Neuropathologica, 1-15

219. Emerging Insights into the Ependymoma Epigenome
Citations:22
Authors: SC Mack, H Witt, X Wang, T Milde, Y Yao, KC Bertrand, A Korshunov, ...
Publication: Brain Pathology 23 (2), 206-209

220. BRAF alteration status and the histone H3F3A gene K27M mutation segregate spinal cord astrocytoma histology
Citations:21
Authors: GM Shankar, N Lelic, CM Gill, AR Thorner, P Van Hummelen, JH Wisoff, ...
Publication: Acta neuropathologica 131 (1), 147-150

221. A Hematogenous Route for Medulloblastoma Leptomeningeal Metastases
Citations:20
Authors: L Garzia, N Kijima, AS Morrissy, P De Antonellis, A Guerreiro-Stucklin, ...
Publication: Cell 172 (5), 1050-1062. e14

222. Poly-ADP-ribose polymerase as a therapeutic target in pediatric diffuse intrinsic pontine glioma and pediatric high-grade astrocytoma
Citations:20
Authors: Y Chornenkyy, S Agnihotri, M Yu, P Buczkowicz, P Rakopoulos, ...
Publication: Molecular cancer therapeutics 14 (11), 2560-2568

225. Gene-expression profiling elucidates molecular signaling networks that can be therapeutically targeted in vestibular schwannoma.
Citations:19
Authors: S Agnihotri, I Gugel, M Remke, A Bornemann, G Pantazis, SC Mack, ...
Publication: Journal of neurosurgery 121 (6), 1434-1445

226. Gene-expression profiling elucidates molecular signaling networks that can be therapeutically targeted in vestibular schwannoma
Citations:19
Authors: S Agnihotri, I Gugel, M Remke, A Bornemann, G Pantazis, SC Mack, ...
Publication: Journal of neurosurgery 121 (6), 1434-1445

227. Gene-expression profiling elucidates molecular signaling networks that can be therapeutically targeted in vestibular schwannoma
Citations:19
Authors: S Agnihotri, I Gugel, M Remke, A Bornemann, G Pantazis, SC Mack, ...
Publication: Journal of neurosurgery 121 (6), 1434-1445

228. Gene-expression profiling elucidates molecular signaling networks that can be therapeutically targeted in vestibular schwannoma
Citations:19
Authors: S Agnihotri, I Gugel, M Remke, A Bornemann, G Pantazis, SC Mack, ...
Publication: Journal of neurosurgery 121 (6), 1434-1445

229. Gene-expression profiling elucidates molecular signaling networks that can be therapeutically targeted in vestibular schwannoma
Citations:19
Authors: S Agnihotri, I Gugel, M Remke, A Bornemann, G Pantazis, SC Mack, ...
Publication: Journal of neurosurgery 121 (6), 1434-1445

230. Gene-expression profiling elucidates molecular signaling networks that can be therapeutically targeted in vestibular schwannoma
Citations:19
Authors: S Agnihotri, I Gugel, M Remke, A Bornemann, G Pantazis, SC Mack, ...
Publication: Journal of neurosurgery 121 (6), 1434-1445

231. Gene-expression profiling elucidates molecular signaling networks that can be therapeutically targeted in vestibular schwannoma
Citations:19
Authors: S Agnihotri, I Gugel, M Remke, A Bornemann, G Pantazis, SC Mack, ...
Publication: Journal of neurosurgery 121 (6), 1434-1445

232. Gene-expression profiling elucidates molecular signaling networks that can be therapeutically targeted in vestibular schwannoma
Citations:19
Authors: S Agnihotri, I Gugel, M Remke, A Bornemann, G Pantazis, SC Mack, ...
Publication: Journal of neurosurgery 121 (6), 1434-1445

233. Gene-expression profiling elucidates molecular signaling networks that can be therapeutically targeted in vestibular schwannoma
Citations:19
Authors: S Agnihotri, I Gugel, M Remke, A Bornemann, G Pantazis, SC Mack, ...
Publication: Journal of neurosurgery 121 (6), 1434-1445

235. MyoD is a tumor suppressor gene in medulloblastoma
Citations:19
Authors: J Dey, AM Dubuc, KD Pedro, D Thirstrup, B Mecham, PA Northcott, X Wu, ...
Publication: Cancer research 73 (22), 6828-6837

236. Canonical TGF‐β Pathway Activity is a Predictor of SHH‐driven Medulloblastoma Survival and Delineates Putative Precursors in Cerebellar Development
Citations:19
Authors: D Aref, CJ Moffatt, S Agnihotri, V Ramaswamy, AM Dubuc, PA Northcott, ...
Publication: Brain Pathology

237. Therapeutic radiation for childhood cancer drives structural aberrations of NF2 in meningiomas
Citations:18
Authors: S Agnihotri, S Suppiah, PD Tonge, S Jalali, A Danesh, JP Bruce, ...
Publication: Nature communications 8 (1), 186

238. Multiple CDK/CYCLIND genes are amplified in medulloblastoma and supratentorial primitive neuroectodermal brain tumor
Citations:18
Authors: M Li, W Lockwood, M Zielenska, P Northcott, YS Ra, E Bouffet, ...
Publication: Cancer genetics 205 (5), 220-231

239. A homing system targets therapeutic T cells to brain cancer
Citations:17
Authors: H Samaha, A Pignata, K Fousek, J Ren, FW Lam, F Stossi, J Dubrulle, ...
Publication: Nature 561 (7723), 331

240. A compartmentalized phosphoinositide signaling axis at cilia is regulated by INPP5E to maintain cilia and promote Sonic Hedgehog medulloblastoma
Citations:17
Authors: SE Conduit, V Ramaswamy, M Remke, DN Watkins, BJ Wainwright, ...
Publication: Oncogene 36 (43), 5969

241. YB-1 is elevated in medulloblastoma and drives proliferation in Sonic hedgehog-dependent cerebellar granule neuron progenitor cells and medulloblastoma cells
Citations:17
Authors: A Dey, M Robitaille, M Remke, C Maier, A Malhotra, A Gregorieff, ...
Publication: Oncogene 35 (32), 4256

243. Genetic drivers of metastatic dissemination in sonic hedgehog medulloblastoma
Citations:17
Authors: NC Jenkins, RR Kalra, A Dubuc, W Sivakumar, CA Pedone, X Wu, ...
Publication: Acta neuropathologica communications 2 (1), 85

244. Genetic drivers of metastatic dissemination in sonic hedgehog medulloblastoma
Citations:17
Authors: NC Jenkins, RR Kalra, A Dubuc, W Sivakumar, CA Pedone, X Wu, ...
Publication: Acta neuropathologica communications 2 (1), 85

245. WIP1 Enhances Tumor Formation in a Sonic Hedgehog–Dependent Model of Medulloblastoma
Citations:17
Authors: TA Doucette, Y Yang, C Pedone, JYH Kim, A Dubuc, PD Northcott, ...
Publication: Neurosurgery 70 (4), 1003-1010

246. Pyruvate kinase inhibits proliferation during postnatal cerebellar neurogenesis and suppresses medulloblastoma formation
Citations:16
Authors: K Tech, AP Tikunov, H Farooq, AS Morrissy, J Meidinger, T Fish, ...
Publication: Cancer research 77 (12), 3217-3230

247. Identification of alsterpaullone as a novel small molecule inhibitor to target group 3 medulloblastoma
Citations:16
Authors: CC Faria, S Agnihotri, SC Mack, BJ Golbourn, RJ Diaz, S Olsen, M Bryant, ...
Publication: Oncotarget 6 (25), 21718

248. De‐escalation of therapy for pediatric medulloblastoma: Trade‐offs between quality of life and survival
Citations:16
Authors: N Henrich, CA Marra, L Gastonguay, D Mabbott, D Malkin, C Fryer, ...
Publication: Pediatric blood & cancer 61 (7), 1300-1304

252. The role of angiogenesis in Group 3 medulloblastoma pathogenesis and survival
Citations:15
Authors: EM Thompson, ST Keir, T Venkatraman, C Lascola, KW Yeom, AB Nixon, ...
Publication: Neuro-oncology 19 (9), 1217-1227

253. Genome-wide DNA methylation analysis reveals epigenetic dysregulation of microRNA-34A in TP53-associated cancer susceptibility
Citations:15
Authors: N Samuel, G Wilson, M Lemire, BI Said, Y Lou, W Li, D Merino, ...
Publication: Journal of Clinical Oncology 34 (30), 3697

254. Neoadjuvant chemotherapy reduces blood loss during the resection of pediatric choroid plexus carcinomas
Citations:15
Authors: C Schneider, I Kamaly-Asl, V Ramaswamy, L Lafay-Cousin, AV Kulkarni, ...
Publication: Journal of Neurosurgery: Pediatrics 16 (2), 126-133

255. G-protein coupled receptor expression patterns delineate medulloblastoma subgroups
Citations:15
Authors: KL Whittier, EA Boese, KN Gibson-Corley, PA Kirby, BW Darbro, Q Qian, ...
Publication: Acta neuropathologica communications 1 (1), 66

256. Intracerebral malignant peripheral nerve sheath tumor in a child with neurofibromatosis Type 1 and middle cerebral artery aneurysm treated with endovascular coil embolization …
Citations:15
Authors: MJ Ellis, S Cheshier, S Sharma, D Armstrong, C Hawkins, E Bouffet, ...
Publication: Journal of Neurosurgery: Pediatrics 8 (4), 346-352

257. Differential patterns of metastatic dissemination across medulloblastoma subgroups
Citations:14
Authors: M Zapotocky, D Mata-Mbemba, D Sumerauer, P Liby, A Lassaletta, ...
Publication: Journal of Neurosurgery: Pediatrics 21 (2), 145-152

258. Basal Suppression of the Sonic Hedgehog Pathway by the G-Protein-Coupled Receptor Gpr161 Restricts Medulloblastoma Pathogenesis
Citations:14
Authors: IS Shimada, SH Hwang, BN Somatilaka, X Wang, P Skowron, J Kim, ...
Publication: Cell Reports 22 (5), 1169-1184

260. Evasion of Cell Senescence Leads to Medulloblastoma Progression
Citations:14
Authors: L Tamayo-Orrego, CL Wu, N Bouchard, A Khedher, SM Swikert, M Remke, ...
Publication: Cell Reports 14 (12), 2925-2937

261. Characterization of novel biomarkers in selecting for subtype specific medulloblastoma phenotypes
Citations:14
Authors: L Liang, C Aiken, R McClelland, LC Morrison, N Tatari, M Remke, ...
Publication: Oncotarget 6 (36), 38881

263. Medulloblastoma
Citations:13
Authors: PA Northcott, GW Robinson, CP Kratz, DJ Mabbott, SL Pomeroy, ...
Publication: Nature Reviews Disease Primers 5 (1), 11

264. Medulloblastoma
Citations:13
Authors: PA Northcott, GW Robinson, CP Kratz, DJ Mabbott, SL Pomeroy, ...
Publication: Nature Reviews Disease Primers 5 (1), 11

265. Heterogeneity within the PF-EPN-B ependymoma subgroup
Citations:13
Authors: FMG Cavalli, JM Hübner, T Sharma, B Luu, M Sill, M Zapotocky, SC Mack, ...
Publication: Acta neuropathologica 136 (2), 227-237

270. Proteomic profiling of high risk medulloblastoma reveals functional biology
Citations:13
Authors: JA Staal, L San Lau, H Zhang, WJ Ingram, AR Hallahan, PA Northcott, ...
Publication: Oncotarget 6 (16), 14584

272. Epigenetic states of cells of origin and tumor evolution drive tumor-initiating cell phenotype and tumor heterogeneity
Citations:13
Authors: KH Chow, DM Shin, MH Jenkins, EE Miller, DJ Shih, S Choi, BE Low, ...
Publication: Cancer research 74 (17), 4864-4874

273. Intertumoral and intratumoral heterogeneity as a barrier for effective treatment of medulloblastoma
Citations:13
Authors: X Wang, V Ramaswamy, M Remke, SC Mack, AM Dubuc, PA Northcott, ...
Publication: Neurosurgery 60 (CN_suppl_1), 57-63

276. Challenges to curing primary brain tumours
Citations:12
Authors: K Aldape, KM Brindle, L Chesler, R Chopra, A Gajjar, MR Gilbert, ...
Publication: Nature Reviews Clinical Oncology, 1

277. Aberrant ERBB4-SRC signaling as a hallmark of group 4 medulloblastoma revealed by integrative phosphoproteomic profiling
Citations:12
Authors: A Forget, L Martignetti, S Puget, L Calzone, S Brabetz, D Picard, ...
Publication: Cancer Cell 34 (3), 379-395. e7

278. MB3W1 is an orthotopic xenograft model for anaplastic medulloblastoma displaying cancer stem cell-and Group 3-properties
Citations:12
Authors: S Dietl, S Schwinn, S Dietl, S Riedel, F Deinlein, S Rutkowski, ...
Publication: BMC cancer 16 (1), 115

281. Mechanism of action and therapeutic efficacy of Aurora kinase B inhibition in MYC overexpressing medulloblastoma
Citations:12
Authors: RJ Diaz, B Golbourn, C Faria, D Picard, D Shih, D Raynaud, M Leadly, ...
Publication: Oncotarget 6 (5), 3359

284. Current concepts in the molecular genetics of pediatric brain tumors: implications for emerging therapies
Citations:12
Authors: MS Tamber, K Bansal, ML Liang, TG Mainprize, B Salhia, P Northcott, ...
Publication: Child's Nervous System 22 (11), 1379-1394

286. H3 K27M mutations are extremely rare in posterior fossa group A ependymoma
Citations:11
Authors: S Ryall, M Guzman, SK Elbabaa, B Luu, SC Mack, M Zapotocky, ...
Publication: Child's Nervous System 33 (7), 1047-1051

289. Opposing Effects of CREBBP Mutations Govern the Phenotype of Rubinstein-Taybi Syndrome and Adult SHH Medulloblastoma
Citations:10
Authors: DJ Merk, J Ohli, ND Merk, V Thatikonda, S Morrissy, M Schoof, ...
Publication: Developmental cell 44 (6), 709-724. e6

290. ATOH1 promotes leptomeningeal dissemination and metastasis of sonic hedgehog subgroup medulloblastomas
Citations:10
Authors: KB Grausam, SDR Dooyema, L Bihannic, H Premathilake, AS Morrissy, ...
Publication: Cancer research 77 (14), 3766-3777

293. Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastoma
Citations:9
Authors: T Purzner, J Purzner, T Buckstaff, G Cozza, S Gholamin, JM Rusert, ...
Publication: Sci. Signal. 11 (547), eaau5147

294. A novel method for rapid molecular subgrouping of medulloblastoma
Citations:9
Authors: S Gómez, A Garrido-Garcia, L Garcia-Gerique, I Lemos, M Suñol, ...
Publication: Clinical Cancer Research 24 (6), 1355-1363

296. WIP1 modulates responsiveness to Sonic Hedgehog signaling in neuronal precursor cells and medulloblastoma
Citations:9
Authors: J Wen, J Lee, A Malhotra, R Nahta, AR Arnold, MC Buss, BD Brown, ...
Publication: Oncogene 35 (42), 5552

298. A microRNA-1280/JAG2 network comprises a novel biological target in high-risk medulloblastoma
Citations:9
Authors: F Wang, M Remke, K Bhat, ET Wong, S Zhou, V Ramaswamy, A Dubuc, ...
Publication: Oncotarget 6 (5), 2709

299. Sleeping Beauty mouse models identify candidate genes involved in gliomagenesis
Citations:9
Authors: I Vyazunova, VI Maklakova, S Berman, I De, MD Steffen, W Hong, ...
Publication: PloS one 9 (11), e113489

303. MR Imaging–Based Radiomic Signatures of Distinct Molecular Subgroups of Medulloblastoma
Citations:8
Authors: M Iv, M Zhou, K Shpanskaya, S Perreault, Z Wang, E Tranvinh, ...
Publication: American Journal of Neuroradiology 40 (1), 154-161

304. Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors
Citations:8
Authors: K Fukuoka, Y Kanemura, T Shofuda, S Fukushima, S Yamashita, ...
Publication: Acta Neuropathologica Communications 6 (1), 134

305. Lateral cerebellum is preferentially sensitive to high sonic hedgehog signaling and medulloblastoma formation
Citations:8
Authors: IL Tan, A Wojcinski, H Rallapalli, Z Lao, RM Sanghrajka, D Stephen, ...
Publication: Proceedings of the National Academy of Sciences 115 (13), 3392-3397

306. Integrated analysis of proteome, phosphotyrosine‐proteome, tyrosine‐kinome, and tyrosine‐phosphatome in acute myeloid leukemia
Citations:8
Authors: J Tong, M Helmy, FMG Cavalli, L Jin, J St‐Germain, R Karisch, P Taylor, ...
Publication: Proteomics 17 (6), 1600361

307. Rapid determination of medulloblastoma subgroup affiliation with mass spectrometry using a handheld picosecond infrared laser desorption probe
Citations:8
Authors: M Woolman, I Ferry, CM Kuzan-Fischer, M Wu, J Zou, T Kiyota, S Isik, ...
Publication: Chemical Science 8 (9), 6508-6519

314. Childhood cerebellar tumours mirror conserved fetal transcriptional programs
Citations:7
Authors: MC Vladoiu, I El-Hamamy, LK Donovan, H Farooq, BL Holgado, ...
Publication: Nature, 1

316. Metastatic group 3 medulloblastoma is driven by PRUNE1 targeting NME1–TGF-β–OTX2–SNAIL via PTEN inhibition
Citations:7
Authors: V Ferrucci, P de Antonellis, FP Pennino, F Asadzadeh, A Virgilio, ...
Publication: Brain 141 (5), 1300-1319

317. Convergence of BMI1 and CHD7 on ERK Signaling in Medulloblastoma
Citations:7
Authors: S Badodi, A Dubuc, X Zhang, G Rosser, MDC Jaeger, MM Kameda-Smith, ...
Publication: Cell Reports 21 (10), 2772-2784

319. Prognostic relevance of miR‐124‐3p and its target TP53INP1 in pediatric ependymoma
Citations:7
Authors: Y Margolin‐Miller, N Yanichkin, K Shichrur, H Toledano, A Ohali, ...
Publication: Genes, Chromosomes and Cancer 56 (8), 639-650

320. Norrin/Frizzled4 signalling in the preneoplastic niche blocks medulloblastoma initiation
Citations:7
Authors: EA Bassett, N Tokarew, EA Allemano, C Mazerolle, K Morin, AJ Mears, ...
Publication: Elife 5, e16764

321. Checkpoint kinase 1 expression is an adverse prognostic marker and therapeutic target in MYC-driven medulloblastoma
Citations:7
Authors: EW Prince, I Balakrishnan, M Shah, JMM Levy, AM Griesinger, I Alimova, ...
Publication: Oncotarget 7 (33), 53881

322. Checkpoint kinase 1 expression is an adverse prognostic marker and therapeutic target in MYC-driven medulloblastoma
Citations:7
Authors: EW Prince, I Balakrishnan, M Shah, JMM Levy, AM Griesinger, I Alimova, ...
Publication: Oncotarget 7 (33), 53881

323. Proteomic analysis of Medulloblastoma reveals functional biology with translational potential
Citations:6
Authors: S Rivero-Hinojosa, L San Lau, M Stampar, J Staal, H Zhang, ...
Publication: Acta Neuropathologica Communications 6 (1), 48

324. Somatostatin receptor subtype 2 (sst2) is a potential prognostic marker and a therapeutic target in medulloblastoma
Citations:6
Authors: M Remke, E Hering, NU Gerber, M Kool, D Sturm, CH Rickert, J Gerß, ...
Publication: Child's Nervous System 29 (8), 1253-1262

325. Medulloblastoma. Neurooncology of CNS tumors
Citations:6
Authors: DT MICHEAL, TR JAMES
Publication: Springer 35, 461-70

329. Survival and functional outcomes of molecularly defined childhood posterior fossa ependymoma: Cure at a cost
Citations:5
Authors: M Zapotocky, K Beera, J Adamski, N Laperierre, S Guger, L Janzen, ...
Publication: Cancer 125 (11), 1867-1876

330. Dual regulatory functions of SUFU and targetome of GLI2 in SHH subgroup medulloblastoma
Citations:5
Authors: WC Yin, T Satkunendran, R Mo, S Morrissy, X Zhang, ES Huang, ...
Publication: Developmental cell 48 (2), 167-183. e5

334. The clinical significance of equivocal findings on spinal MRI in children with medulloblastoma
Citations:5
Authors: J Bennett, R Ashmawy, V Ramaswamy, D Stephens, E Bouffet, ...
Publication: Pediatric blood & cancer 64 (8), e26472

335. Principles of Posterior Fossa Surgery: Surgical Management
Citations:5
Authors: A Nanda
Publication: Thieme Medical Pub

336. Does thiopentone delay recovery in children premedicated with midazolam?
Citations:5
Authors: P MORLEY‐FORSTER, J McALLISTER, H VANDENBERGHE, ...
Publication: Pediatric Anesthesia 7 (4), 279-285

337. DNA hypermethylation within TERT promoter upregulates TERT expression in cancer
Citations:4
Authors: DD Lee, R Leão, M Komosa, M Gallo, CH Zhang, T Lipman, M Remke, ...
Publication: The Journal of Clinical Investigation 129 (1)

341. The Mir-17/92 Polycistron Is Amplified and Upregulated in Sonic Hedgehog-Driven Medulloblastomas and Induced by N-Myc in Sonic Hedgehog-Treated Cerebellar Neural Precursors
Citations:4
Authors: PA Northcott, A Fernandez-L, JP Hagan, DW Ellison, JT Rutka, CM Croce, ...
Publication: Neuro-Oncology 11 (6), 924-924

342. Craniospinal irradiation as part of re-irradiation for children with recurrent intracranial ependymoma
Citations:3
Authors: DS Tsang, L Murray, V Ramaswamy, M Zapotocky, U Tabori, U Bartels, ...
Publication: Neuro-oncology 21 (4), 547-557

347. FSTL5 improves prognostic subclassification of medulloblastoma
Citations:3
Authors: M Remke, T Hielscher, A Korshunov, PA Northcott, S Bender, M Kool, ...
Publication: Cancer Research 71 (8 Supplement), 3447-3447

348. Neoadjuvant chemotherapy reduces operative haemorrhage and improves resection for choroid plexus carcinomas
Citations:3
Authors: ID Kamaly-Asl, E Bouffet, W Halliday, JM Drake, JT Rutka, PB Dirks, ...
Publication: Childs Nerv Syst 21, 852

350. Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes
Citations:2
Authors: T Sharma, EC Schwalbe, D Williamson, M Sill, V Hovestadt, M Mynarek, ...
Publication: Acta Neuropathologica, 1-18

352. Sleeping Beauty insertional mutagenesis reveals important genetic drivers of central nervous system embryonal tumors
Citations:2
Authors: PJ Beckmann, JD Larson, AT Larsson, JP Ostergaard, S Wagner, ...
Publication: Cancer research 79 (5), 905-917

354. Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma
Citations:2
Authors: SA Kahn, X Wang, RT Nitta, S Gholamin, J Theruvath, G Hutter, TD Azad, ...
Publication: Nature communications 9 (1), 4121

355. Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma
Citations:2
Authors: SA Kahn, X Wang, RT Nitta, S Gholamin, J Theruvath, G Hutter, TD Azad, ...
Publication: Nature communications 9 (1), 4121

356. Reproducibility of the NanoString 22‐gene molecular subgroup assay for improved prognostic prediction of medulloblastoma
Citations:2
Authors: LF Leal, AF Evangelista, FE de Paula, G Caravina Almeida, AC Carloni, ...
Publication: Neuropathology 38 (5), 475-483

357. CD271+ cells are diagnostic and prognostic and exhibit elevated MAPK activity in SHH medulloblastoma
Citations:2
Authors: L Liang, L Coudière-Morrison, N Tatari, M Stromecki, A Fresnoza, ...
Publication: Cancer research 78 (16), 4745-4759

358. MAP4K4 controlled integrin β1 activation and c-Met endocytosis are associated with invasive behavior of medulloblastoma cells
Citations:2
Authors: D Tripolitsioti, KS Kumar, A Neve, J Migliavacca, C Capdeville, ...
Publication: Oncotarget 9 (33), 23220

359. 5-Hydroxymethylcytosine preferentially targets genes upregulated in isocitrate dehydrogenase 1 mutant high-grade glioma
Citations:2
Authors: WK Glowacka, H Jain, M Okura, A Maimaitiming, Y Mamatjan, R Nejad, ...
Publication: Acta neuropathologica 135 (4), 617-634

360. Characterization of a novel OTX 2‐driven stem cell program in Group 3 and Group 4 medulloblastoma
Citations:2
Authors: M Stromecki, N Tatari, LC Morrison, R Kaur, J Zagozewski, G Palidwor, ...
Publication: Molecular oncology 12 (4), 495-513

361. miR miR on the wall, who’s the most malignant medulloblastoma miR of them all?
Citations:2
Authors: X Wang, BL Holgado, V Ramaswamy, S Mack, K Zayne, M Remke, X Wu, ...
Publication: Neuro-oncology 20 (3), 313-323

362. Societal preferences in the treatment of pediatric medulloblastoma: Balancing risk of death and quality of life
Citations:2
Authors: A Khakban, T Mohammadi, LD Lynd, D Mabbott, E Bouffet, L Gastonguay, ...
Publication: Pediatric blood & cancer 64 (6), e26340

365. Integrated genomics elucidates relative spatial homogeneity of embryonal brain tumors
Citations:2
Authors: M Remke, F Cavalli, AS Morrissy, V Ramaswamy, D Jones, R Packer, ...
Publication: Molecular and cellular pediatrics 2 (S1), A10

367. The eEF2 kinase confers tumor cell adaptation to nutrient deprivation
Citations:2
Authors: G Leprivier, M Remke, A Dubuc, B Rotblat, M Kool, S Agnihotri, ...
Publication: Cell 153 (5), 1064-1079

368. 0076. MECHANISM OF ACTION AND THERAPEUTIC APPLICATION OF AURORA KINASE B INHIBITION IN c-MYC OVEREXPRESSING MEDULLOBLASTOMA
Citations:2
Authors: R Diaz, B Golbourn, C Faria, D Shih, D MacKenzie, D Picard, M Bryant, ...
Publication: Neuro-oncology 15 (suppl_1)

369. 0076. MECHANISM OF ACTION AND THERAPEUTIC APPLICATION OF AURORA KINASE B INHIBITION IN c-MYC OVEREXPRESSING MEDULLOBLASTOMA
Citations:2
Authors: R Diaz, B Golbourn, C Faria, D Shih, D MacKenzie, D Picard, M Bryant, ...
Publication: Neuro-oncology 15 (suppl_1)

372. Molecular subtypes in medulloblastoma: an International meta-analysis for profiles, genetic aberrations, clinicopathological features AND SURVIVAL
Citations:2
Authors: M Kool, J Koster, M Remke, A Korshunov, T Hielscher, H Witt, P Northcott, ...
Publication: Klinische Pädiatrie 223 (06), A9

373. The mir-17/92 polycistron is amplified and upregulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors
Citations:2
Authors: PA Northeott, A Fernandez-L, JP Hagan, DW Ellison, JT Rutka, CM Croce, ...
Publication: NEURO-ONCOLOGY 11 (6), 909-910

377. ID1 Is Critical for Tumorigenesis and Regulates Chemoresistance in Glioblastoma
Citations:1
Authors: R Sachdeva, M Wu, S Smiljanic, O Kaskun, K Ghannad-Zadeh, A Celebre, ...
Publication: Cancer research 79 (16), 4057-4071

378. Engineering Genetic Predisposition in Human Neuroepithelial Stem Cells Recapitulates Medulloblastoma Tumorigenesis
Citations:1
Authors: M Huang, J Tailor, Q Zhen, AH Gillmor, ML Miller, H Weishaupt, J Chen, ...
Publication: Cell Stem Cell

379. Myc and loss of p53 cooperate to drive formation of choroid plexus carcinoma
Citations:1
Authors: J Wang, DM Merino, N Light, BL Murphy, YD Wang, X Guo, AP Hodges, ...
Publication: Cancer research 79 (9), 2208-2219

380. Application of a Neural Network Whole Transcriptome–Based Pan-Cancer Method for Diagnosis of Primary and Metastatic Cancers
Citations:1
Authors: JK Grewal, B Tessier-Cloutier, M Jones, S Gakkhar, Y Ma, R Moore, ...
Publication: JAMA network open 2 (4), e192597-e192597

381. BMI1 is a therapeutic target in recurrent medulloblastoma
Citations:1
Authors: D Bakhshinyan, C Venugopal, AA Adile, N Garg, B Manoranjan, R Hallett, ...
Publication: Oncogene, 1

382. TGF-β Determines the Pro-migratory Potential of bFGF Signaling in Medulloblastoma
Citations:1
Authors: KS Kumar, A Neve, ASG Stucklin, CM Kuzan-Fischer, EJ Rushing, ...
Publication: Cell reports 23 (13), 3798-3812. e8

386. HG-53HYPERMUTATION AND NEOANTIGEN FORMATION PREDICT RESPONSE TO IMMUNE CHECKPOINT INHIBITION IN CHILDHOOD BIALLELIC MISMATCH REPAIR DEFICIENT GLIOBLASTOMA
Citations:1
Authors: B Campbell, E Bouffet, V Larouche, G Mason, A Reddy, M Osborn, ...
Publication: Neuro-Oncology 18 (suppl_3), iii59-iii60

388. PTPS-08 Hematogenous dissemination of medulloblastoma metastases to the leptomeninges
Citations:1
Authors: L Garzia, N Kijima, A Morrissy, L Donovan, X Wu, B Luu, V Ramaswamy, ...
Publication: Neuro-oncology 17 (suppl_5), v180-v180

391. Integrative Genomic Analyses of Atypical Teratoid Rhabdoid Tumours (ATRTs)
Citations:1
Authors: J Torchia, D Picard, DA Kwang, M Dzamba, KC Ho, SK Kim, L Louterneau, ...
Publication: Cancer Genetics 207 (9), 447-448

392. Metastasis and Tumor Recurrence from Rare SOX9-Positive Cells in MYCN-Driven Medulloblastoma
Citations:1
Authors: FJ Swartling, V Savov, M Čančer, S Bolin, G Fotaki, A Dubuc, M Remke, ...
Publication: Neuro-oncology 16 (Suppl 3), iii28

393. Integrative genomic analyses identify recurrent structural alterations in atypical teratoid rhabdoid tumors (ATRTs)
Citations:1
Authors: J Torchia, D Picard, K Ching Ho, DA Khuong-Quang, L Louterneau, ...
Publication: Neuro-Oncology 16

394. Integrative genomic analyses identify recurrent structural alterations in atypical teratoid rhabdoid tumors (ATRTs)
Citations:1
Authors: J Torchia, D Picard, K Ching Ho, DA Khuong-Quang, L Louterneau, ...
Publication: Neuro-Oncology 16

395. Integrative genomic analyses identify recurrent structural alterations in atypical teratoid rhabdoid tumors (ATRTs)
Citations:1
Authors: J Torchia, D Picard, K Ching Ho, DA Khuong-Quang, L Louterneau, ...
Publication: Neuro-Oncology 16

396. ATYPICAL TERATOID RHABDOID TUMOUR
Citations:1
Authors: AI Bertozzi, C Munzer, F Fouyssac, N Andre, S Boetto, P Leblond, ...
Publication: Neuro-oncology 16 (suppl_1), i1-i9

397. MEDULLOBLASTOMA
Citations:1
Authors: G Vaidyanathan, S Gururangan, D Bigner, M Zalutsky, M Morfouace, ...
Publication: Neuro-Oncology 16 (suppl_1), i71-i96

398. NO-125. COMBINATION OF BEVACIZUMAB AND EVEROLIMUS IN PATIENTS WITH REFRACTORY, PROGRESSIVE INTRACRANIAL MENINGIOMA: UPDATED RESULTS FROM A PHASE II TRIAL OF THE SARAH CANNON …
Citations:1
Authors: K Shih, S Chowdhary, P Rosenblatt, A Weir, G Shepard, J Williams, ...
Publication: Neuro-oncology 15 (suppl_3)

399. PC-015. MEDULLOBLASTOMA IN THE OPERATIVE THEATER
Citations:1
Authors: S Perreault, K Chao, V Ramaswamy, D Shih, M Remke, B Luu, ...
Publication: Neuro-oncology 15 (suppl_3)

400. PC-015. MEDULLOBLASTOMA IN THE OPERATIVE THEATER
Citations:1
Authors: S Perreault, K Chao, V Ramaswamy, D Shih, M Remke, B Luu, ...
Publication: Neuro-oncology 15 (suppl_3)

401. KCNJ2 constitutes a marker and therapeutic target of high-risk medulloblastomas.
Citations:1
Authors: F Valdora, F Freier, L Garzia, V Ramaswamy, C Seyler, T Hielscher, ...
Publication: Cancer Research 73 (8 Supplement), 5050-5050

402. INTEGRATIVE GENOMIC ANALYSES IDENTIFY RECURRENT STRUCTURAL ALTERATIONS IN ATYPICAL TERATOID RHABDOID TUMOURS (ATRTS)
Citations:1
Authors: J Torchia, DA Khuong-Quang, KC Ho, D Picard, L Letourneau, T Chan, ...
Publication: NEURO-ONCOLOGY 15, 48-49

403. 0086. EFFECTIVE TARGETING OF THE HGF/c-MET PATHWAY IN MEDULLOBLASTOMA
Citations:1
Authors: C Faria, A Dubuc, B Golbourn, R Diaz, S Agnihotri, N Sabha, A Luck, ...
Publication: Neuro-oncology 15 (suppl_1)

404. 0086. EFFECTIVE TARGETING OF THE HGF/c-MET PATHWAY IN MEDULLOBLASTOMA
Citations:1
Authors: C Faria, A Dubuc, B Golbourn, R Diaz, S Agnihotri, N Sabha, A Luck, ...
Publication: Neuro-oncology 15 (suppl_1)

405. ICGC PedBrain-dissecting the genomic complexity underlying medulloblastoma using whole-genome sequencing
Citations:1
Authors: N Jäger, DTW Jones, M Kool, T Zichner, B Hutter, M Sultan, YJ Cho, ...
Publication: BMC Proceedings 6 (6), P43

406. Ependymoma
Citations:1
Authors: H Witt, S Mack, N Jäger, DTW Jones, S Bender, A Stütz, T Milde, ...
Publication: Neuro-oncology 14 (suppl_1), i33-i42

407. WNT activation by lithium abrogates mutant TP53 radiation resistance in medulloblastoma
Citations:1
Authors: N Zhukova, D Martin, T Lipman, P Castelo-Branco, C Zhang, M Fraser, ...
Publication: NEURO-ONCOLOGY 14, 100-100

408. Ependymoma
Citations:1
Authors: T Milde, S Kleber, A Korshunov, H Witt, T Hielscher, P Koch, H Koch, ...
Publication: Neuro-oncology 14 (suppl_1), i33-i42

409. WNT ACTIVATION BY LITHIUM ABROGATES MUTANT TP53 RADIATION RESISTANCE IN MEDULLOBLASTOMA
Citations:1
Authors: N Zhukova, D Martin, T Lipman, P Castelo-Branco, C Zhang, M Fraser, ...
Publication: NEURO-ONCOLOGY 14, 100-100

410. ICGC PedBrain Tumor-Next-generation sequencing identifies novel subgroup-specific mutations and copy number aberrations in medulloblastoma
Citations:1
Authors: DTW Jones, N Jaeger, YJ Cho, TJ Pugh, T Rausch, A Stuetz, T Zichner, ...
Publication: Cancer Research 72 (8 Supplement), 4872-4872

412. Histone deacetylases 5 and 9 in medulloblastoma: novel markers for risk stratification and role in tumor cell growth
Citations:1
Authors: T Milde, I Oehme, A Korshunov, A Kopp-Schneider, M Remke, P Northcott, ...
Publication: Clin. Cancer Res

413. Murine metastatic medulloblastoma driven by Sleeping Beauty transposition identifies genes and pathways important for medulloblastoma initiation and progression
Citations:1
Authors: X Wu, L Collier, J Mcleod, P Northcott, S Croul, J MacDonald, J Zhang, ...
Publication: Cancer Research 68 (9 Supplement), 4135-4135

414. Identification of known and novel recurrent amplified oncogenes in pediatric medulloblastoma
Citations:1
Authors: P Northcott, Y Nakahara, J Peacock, D Ellison, S Croul, L Feuk, ...
Publication: NEURO-ONCOLOGY 9 (4), 554-554

418. Subgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastoma
Citations:
Authors: AK Park, JY Lee, H Cheong, V Ramaswamy, SH Park, M Kool, JH Phi, ...
Publication: BMC Cancer 19 (1), 571

419. Single-Cell Transcriptomics in Medulloblastoma Reveals Tumor-Initiating Progenitors and Oncogenic Cascades during Tumorigenesis and Relapse
Citations:
Authors: L Zhang, X He, X Liu, F Zhang, LF Huang, AS Potter, L Xu, W Zhou, ...
Publication: Cancer Cell

420. Molecular correlates of cerebellar mutism syndrome in medulloblastoma
Citations:
Authors: R Jabarkheel, N Amayiri, D Yecies, Y Huang, S Toescu, L Nobre, ...
Publication: Neuro-Oncology

421. Predictors of Posterior Fossa Syndrome: Results From an International Multicenter Cohort Study of Molecularly Characterized Medulloblastoma Patients
Citations:
Authors: R Jabarkheel, N Amayiri, DW Yecies, Y Huang, S Toescu, D Mabbott, ...
Publication: Neurosurgery 66 (Supplement_1), nyz310_198

422. An autocrine ActivinB mechanism drives TGFβ/Activin signaling in Group 3 medulloblastoma
Citations:
Authors: M Morabito, M Larcher, FMG Cavalli, C Foray, A Forget, L Mirabal‐Ortega, ...
Publication: EMBO molecular medicine 11 (8)

423. High-resolution structural genomics reveals new therapeutic vulnerabilities in glioblastoma
Citations:
Authors: MJ Johnston, A Nikolic, N Ninkovic, P Guilhamon, FMG Cavalli, ...
Publication: Genome research 29 (8), 1211-1222

424. A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor
Citations:
Authors: P Sin-Chan, I Mumal, T Suwal, B Ho, X Fan, I Singh, Y Du, M Lu, N Patel, ...
Publication: Cancer Cell 36 (1), 51-67. e7

426. Reply to ‘Assembling the brain trust: the multidisciplinary imperative in neuro-oncology’
Citations:
Authors: K Aldape, KM Brindle, L Chesler, R Chopra, A Gajjar, MR Gilbert, ...
Publication: Nature Reviews Clinical Oncology, 1

427. TNF superfamily cytokines overcome immune evasion in medulloblastoma
Citations:
Authors: R Wechsler-Reya, A Garancher, H Suzuki, S Haricharan, MB Masihi, ...
Publication: The Journal of Immunology 202 (1 Supplement), 194.41-194.41

428. Picosecond infrared laser desorption mass spectrometry identifies medulloblastoma subgroups on intrasurgical timescales
Citations:
Authors: M Woolman, CM Kuzan-Fischer, I Ferry, T Kiyota, B Luu, M Wu, ...
Publication: Cancer research 79 (9), 2426-2434

429. Intratumoral genetic and functional heterogeneity in pediatric glioblastoma
Citations:
Authors: M Hoffman, AH Gillmor, DJ Kunz, MJ Johnston, A Nikolic, K Narta, ...
Publication: Cancer research 79 (9), 2111-2123

430. Modulating native GABAA receptors in medulloblastoma with positive allosteric benzodiazepine-derivatives induces cell death
Citations:
Authors: L Kallay, H Keskin, A Ross, M Rupji, OA Moody, X Wang, G Li, T Ahmed, ...
Publication: Journal of neuro-oncology 142 (3), 411-422

431. IMMU-20. IMMUNE AND TUMOR BIOMARKERS OF OUTCOME IN REPLICATION REPAIR DEFICIENT BRAIN TUMORS TREATED WITH IMMUNE CHECKPOINT INHIBITORS: UPDATES FROM THE INTERNATIONAL …
Citations:
Authors: E Bouffet, S Sudhaman, J Chung, B Campbell, J Kelly, A Coblentz, ...
Publication: Neuro-Oncology 21 (Supplement_2), ii96-ii97

432. MEDU-26. LATENT SOX9-POSITIVE CELLS RESPONSIBLE FOR MYC-DRIVEN MEDULLOBLASTOMA RECURRENCE
Citations:
Authors: S Bolin, V Savov, A Borgenvik, G Rosen, A Garancher, AS Rahmanto, ...
Publication: Neuro-Oncology 21 (Supplement_2), ii108-ii109

433. LGG-16. PREDICTORS OF OUTCOME IN BRAF-V600E PEDIATRIC GLIOMAS TREATED WITH BRAF INHIBITORS: A REPORT FROM THE PLGG TASKFORCE
Citations:
Authors: L Nobre, M Zapotocky, S Ryall, AG Stucklin, J Bennett, L Baroni, ...
Publication: Neuro-Oncology 21 (Supplement_2), ii102-ii102

434. HGG-19. MOLECULAR ANALYSIS UNCOVERS 3 DISTINCT SUBGROUPS AND MULTIPLE TARGETABLE GENE FUSIONS IN INFANT GLIOMAS
Citations:
Authors: AG Stücklin, S Ryall, K Fukuoka, M Zapotocky, A Lassaletta, A Arnoldo, ...
Publication: Neuro-Oncology 21 (Supplement_2), ii90-ii91

436. MATCHING OF SINGLE CELL TRANSCRIPTOMICS FROM CEREBELLAR DEVELOPMENT IDENTIFIES PUTATIVE SUBGROUP SPECIFIC CELLS OF ORIGIN FOR MEDULLOBLASTOMA
Citations:
Authors: I El-Hamamy, M Vladoiu, L Donovan, H Farooq, B Holgado, ...
Publication: NEURO-ONCOLOGY 21, 111-112

437. TUMOR NECROSIS FACTOR OVERCOMES IMMUNE EVASION IN P53-MUTANT MEDULLOBLASTOMA
Citations:
Authors: A Garancher, H Suzuki, S Haricharan, MB Masihi, JM Rusert, PS Norris, ...
Publication: NEURO-ONCOLOGY 21, 93-93

438. A COMMON FETAL DEVELOPMENTAL ORIGIN FOR PEA EPENDYMOMA, PFB EPENDYMOMA, AND CEREBELLAR PILOCYTIC ASTROCYTOMAS
Citations:
Authors: M Vladoiu, I El-Hamamy, L Donovan, H Farooq, B Holgado, F Notta, ...
Publication: NEURO-ONCOLOGY 21, 79-80

440. COMBINATIONAL CAR T-CELL AND EPIGENETIC MODIFIER THERAPY TO TARGET POSTERIOR FOSSA TUMORS
Citations:
Authors: L Donovan, K Bielamowicz, S Joseph, A Delaidelli, P Sorenson, N Ahmed, ...
Publication: NEURO-ONCOLOGY 21, 93-94

442. DNA hypermethylation within TERT promoter upregulates TERT expression in cancer
Citations:
Authors: DD Lee, R Leão, M Komosa, M Gallo, CH Zhang, T Lipman, M Remke, ...
Publication: The Journal of clinical investigation 129 (4), 1801-1801

443. Retraction Note: A homing system targets therapeutic T cells to brain cancer
Citations:
Authors: H Samaha, A Pignata, K Fousek, J Ren, FW Lam, F Stossi, J Dubrulle, ...
Publication: Nature 567 (7746), 132

445. Infusion of 5-Azacytidine (5-AZA) into the fourth ventricle or resection cavity in children with recurrent posterior Fossa Ependymoma: a pilot clinical trial
Citations:
Authors: DI Sandberg, B Yu, R Patel, J Hagan, E Miesner, J Sabin, S Smith, ...
Publication: Journal of neuro-oncology 141 (2), 449-457

446. Identification of CD24 as a marker of Patched1 deleted medulloblastoma-initiating neural progenitor cells
Citations:
Authors: JP Robson, M Remke, M Kool, E Julian, A Korshunov, SM Pfister, ...
Publication: PLOS ONE 14 (1), e0210665

449. RETRACTION: A homing system targets therapeutic T cells to brain cancer (Retraction of Vol 561, Pg 331, 2018)
Citations:
Authors: H Samaha, A Pignata, K Fousek, J Ren, FW Lam, F Stossi, J Dubrulle, ...
Publication: Nature 567 (7746), 42-42

450. Antitumor Activities and Cellular Changes Induced by TrkB Inhibition in Medulloblastoma
Citations:
Authors: A Thomaz, K de Vargas Pinheiro, BK Souza, L Gregianin, AL Brunetto, ...
Publication: bioRxiv, 566000

451. HDAC and MAPK/ERK Inhibitors Cooperate to Reduce Viability and Stemness Phenotype in Medulloblastoma
Citations:
Authors: M da Cunha Jaeger, EC Ghisleni, PS Cardoso, M Siniglaglia, T Falcon, ...
Publication: bioRxiv, 521393

453. A functional genomics approach to identify pathways of drug resistance in medulloblastoma
Citations:
Authors: KC Bertrand, CC Faria, P Skowron, A Luck, L Garzia, X Wu, S Agnihotri, ...
Publication: Acta Neuropathologica Communications 6 (1), 146

454. GENE-21. A COMMON FETAL DEVELOPMENTAL ORIGIN FOR PFA EPENDYMOMA, PFB EPENDYMOMA, AND CEREBELLAR PILOCYTIC ASTROCYTOMAS?
Citations:
Authors: M Vladoiu, I El-Hamamy, L Donovan, BH Lopez, H Farooq, C Kleinman, ...
Publication: Neuro-Oncology 20 (suppl_6), vi107-vi107

455. TMOD-35. CAN RARE SOX9-POSITIVE CELLS INCITE MYC-DRIVEN MEDULLOBLASTOMA RECURRENCE?
Citations:
Authors: S Bolin, V Savov, A Borgenvik, A Garancher, G Rosén, A Rahmanto, ...
Publication: Neuro-Oncology 20 (suppl_6), vi276-vi276

457. PDTM-21. MATCHING OF SINGLE CELL TRANSCRIPTOMICS FROM CEREBELLAR DEVELOPMENT IDENTIFIES PUTATIVE SUBGROUP SPECIFIC CELLS OF ORIGIN FOR MEDULLOBLASTOMA
Citations:
Authors: I El-Hamamy, M Vladoiu, L Donovan, F Cavalli, V Ramaswamy, H Farooq, ...
Publication: Neuro-Oncology 20 (suppl_6), vi208-vi208

458. Publisher Correction: Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma
Citations:
Authors: SA Kahn, X Wang, RT Nitta, S Gholamin, J Theruvath, G Hutter, TD Azad, ...
Publication: Nature Communications 9 (1), 4651

460. OS5. 1 Molecular subgroups of low-and high-grade gliomas diagnosed in the first year of life
Citations:
Authors: A Guerreiro Stücklin, S Ryall, K Fukuoka, M Zapotocky, A Lassaletta, ...
Publication: Neuro-Oncology 20 (suppl_3), iii224-iii224

465. EPEN-23. MOLECULAR HETEROGENEITY AMONG PEDIATRIC POSTERIOR FOSSA EPENDYMOMA
Citations:
Authors: KW Pajtler, J Wen, M Sill, T Lin, JM Hübner, V Ramaswamy, ...
Publication: Neuro-Oncology 20 (suppl_2), i77-i78

466. EPEN-23. MOLECULAR HETEROGENEITY AMONG PEDIATRIC POSTERIOR FOSSA EPENDYMOMA
Citations:
Authors: KW Pajtler, J Wen, M Sill, T Lin, JM Hübner, V Ramaswamy, ...
Publication: Neuro-Oncology 20 (suppl_2), i77-i78

467. MBRS-52. TARGETING PRUNE-1 IN A GEMM OF METASTATIC MEDULLOBLASTOMA: A POTENTIAL ROUTE OF INHIBITION FOR NEW FUTURE THERAPIES
Citations:
Authors: V Ferrucci, P de Antonellis, FP Pennino, F Asadzadeh, R Siciliano, ...
Publication: Neuro-Oncology 20 (suppl_2), i139-i139

468. EPEN-23. MOLECULAR HETEROGENEITY AMONG PEDIATRIC POSTERIOR FOSSA EPENDYMOMA
Citations:
Authors: KW Pajtler, J Wen, M Sill, T Lin, JM Hübner, V Ramaswamy, ...
Publication: Neuro-Oncology 20 (suppl_2), i77-i78

469. EMBR-17. PINEOBLASTOMA SEGREGATES INTO MOLECULAR SUBTYPES WITH DISTINCT CLINICOPATHOLOGIC FEATURES: REPORT FROM THE RARE BRAIN TUMOR CONSORTIUM
Citations:
Authors: B Li, A Vasiljevic, B Ho, J Norman, M Lu, E Hwang, J Hansford, A Jouvet, ...
Publication: Neuro-Oncology 20 (Suppl 2), i72

470. HGG-17. TUMOR MUTATIONAL BURDEN ANALYSIS OF PEDIATRIC TUMORS PROVIDES A DIAGNOSTIC TOOL FOR GERMLINE REPLICATION REPAIR DEFICIENCY AND PREDICT RESPONSE TO IMMUNE CHECKPOINT …
Citations:
Authors: BB Campbell, N Light, D Fabrizio, E Bouffet, V Larouche, D Samuel, ...
Publication: Neuro-Oncology 20 (Suppl 2), i92

473. EPEN-28. HETEROGENEITY WITHIN THE PFB EPENDYMOMA SUBGROUP
Citations:
Authors: F Cavalli, JM Hübner, T Sharma, M Sill, B Luu, M Zapotocky, A Korshunov, ...
Publication: Neuro-Oncology 20 (Suppl 2), i79

474. EPEN-31. SUBGROUP SPECIFIC LONG-TERM SURVIVAL AND NEUROCOGNITIVE OUTCOMES IN POSTERIOR FOSSA EPENDYMOMA (PFE)
Citations:
Authors: M Zapotocky, K Beera, J Adamski, S Guger, L Janzen, N Laperierre, ...
Publication: Neuro-Oncology 20 (Suppl 2), i79

475. 15 CD271/p75NTR is a novel diagnostic marker, prognostic indicator and therapeutic target for SHH medulloblastoma
Citations:
Authors: L Liang, LC Morrison, N Tatari, M Stromecki, A Fresnoza, CJ Porter, ...
Publication: Canadian Journal of Neurological Sciences 45 (S3), S12-S13

477. how do parents and providers trade-off between disability and survival? Preferences in the treatment of pediatric medulloblastoma
Citations:
Authors: A Khakban, T Mohammadi, LD Lynd, DJ Mabbott, E Bouffet, ...
Publication: Patient preference and adherence 12, 2103

478. Subclonal architecture, evolutionary trajectories and patterns of inheritance of germline variants in pediatric glioblastoma
Citations:
Authors: M Hoffman, AH Gillmor, DJ Kunz, MJ Johnston, A Nikolic, K Karta, J King, ...
Publication: bioRxiv, 434241

480. Chromatin Blueprint Of Glioblastoma Stem Cells Reveals Common Drug Candidates For Distinct Subtypes
Citations:
Authors: P Guilhamon, MM Kushida, G MacLeod, SAM Tonekaboni, FMG Cavalli, ...
Publication: bioRxiv, 370726

482. Csig-15. Proteomic And Phosphoproteomic Analysis Of Human Medulloblastoma Reveals Distinct Activated Pathways Between Subgroups
Citations:
Authors: A Forget, M Loredana, S Brabetz, D Picard, S Puget, L Calzone, P Poullet, ...
Publication: Neuro-oncology 19 (suppl_6), vi52-vi53

484. Pdtm-49. Global Reduction In H3k27me3, Similar To H3k27m Mutant Gliomas, Is A Molecular Surrogate For Pediatric Posterior Fossa-Group A Ependymomas
Citations:
Authors: S Vennneti, P Panwalkar, J Clark, V Ramaswamy, D Hawes, F Yang, ...
Publication: Neuro-oncology 19 (suppl_6), vi200-vi201

485. Path-32. Molecular Heterogeneity Among Pediatric Posterior Fossa Ependymoma
Citations:
Authors: KW Pajtler, J Wen, M Sill, T Lin, J Hübner, V Ramaswamy, D Jones, H Witt, ...
Publication: Neuro-oncology 19 (suppl_6), vi177-vi177

487. Tmod-31. Rare Sox9+ Cells Behind Myc-driven Medulloblastoma Recurrence
Citations:
Authors: S Bolin, V Savov, A Borgenvik, A Garancher, G Rosén, AS Rahmanto, ...
Publication: Neuro-oncology 19 (Suppl 6), vi260

488. Pdtm-46. Targeting Metabolic Adaptation In Myc Driven Pediatric Neuronal Tumors
Citations:
Authors: A Delaidelli, GL Negri, A Jan, B Jansonius, JKM Lim, G Leprivier, M Kool, ...
Publication: Neuro-oncology 19 (Suppl 6), vi199

489. Pdtm-48. Peroxiredoxin1 Is A Therapeutic Target In Group-3 Medulloblastoma
Citations:
Authors: S Babu, R Omar, H Fediuk, L Li, L Coudiere-Morrision, W Wang, J Pu, ...
Publication: Neuro-oncology 19 (Suppl 6), vi200

491. GPC2 is an oncogene and immunotherapeutic target in high-risk neuroblastoma
Citations:
Authors: KR Bosse, P Raman, M Lane, RT Sussman, JL Harenza, D Martinez, ...
Publication: Cancer Research 77 (13 Supplement), 685-685

492. Abstract NG05: TP53-mediated human cancer susceptibility is defined by epigenetic dysregulation of microRNA-34A
Citations:
Authors: N Samuel, G Wilson, G Deblois, BI Said, NW Fischer, M Lemire, Y Lou, ...
Publication: Cancer Research 77 (13 Supplement), NG05-NG05

494. Setting the stage for metastasis: changes in the activity of specific pathways in medulloblastoma primary tumours correlates with an increased frequency of metastasis
Citations:
Authors: S Matan-Lithwick, FMG Cavalli, N Kijima, L Donovan, S Morrissy, L Garzia, ...
Publication: F1000Research 6

495. Global reduction in H3K27me3 is a molecular surrogate for pediatric posterior fossa-group A ependymomas
Citations:
Authors: P Panwalkar, J Clark, V Ramaswamy, D Hawes, F Yang, C Dunham, ...
Publication: JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 76 (6), 497-497

496. Molecular Heterogeneity Among Pediatric Posterior Fossa Ependymomas
Citations:
Authors: D Ellison, K Pajtler, J Wen, M Sill, T Lin, J Hubner, V Ramaswamy, ...
Publication: JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 76 (6), 497-498

500. MEDU-47. PEROXIREDOXIN1 IS A THERAPEUTIC TARGET IN GROUP-3 MEDULLOBLASTOMAS
Citations:
Authors: B Sajesh, R Omar, J Jarmasz, H Stirton, L Morrison, W Wang, J Pu, ...
Publication: Neuro-Oncology 19 (suppl_4), iv47-iv47
